A new series of barbituric acid derivatives w prepared and characterized by Fourier-transform infrared spectroscopy (FTIR), proton nuclear magnetic resonance ( 1 H-NMR) and nuclear magnetic resonance 
Introduction
Sulfadiazine is one of the antibiotic drugs that belong to the sulfonamide group; it has been utilized in veterinary and human therapy over 60 years [1] . Also, it is utilized for the treatment of urinary tract infections (UTIs) [2] , and in clinic as a topical agent either alone or in combination with other compounds in the treatment of wound and burn infections [3] . Thiazoles are a group of heterocyclic compounds that possess a wide variety of biological activities and their utility as medicaments is very much established [4] . The applications of thiazoles were found in drug development for the treatment of inflammation, bacterial, allergies, HIV infections hypertension, schizophrenia, hypnotics and in the treatment of pain [5] . Barbituric acid, or pyrimidine-2,4,6-(1H,3H,5H)-trione,H 3 BA, that contains five hetero atoms (three O and two N) is commonly known as barbiturates [6] . It was prepared by Adolf Von Baeyer in 1864 from a combination of the urea and malonic acid [7] . Barbituric acid has been extensively utilized in biological and medical studiws for many years, the best known of which is their sedative activity in the central nervous system [8] . They are a favour in medicinal chemistry as anticonvulsants, sedatives, hypnotics and anxiolytic agents [9] .
Experimental
All reagents and solvents were purchased from commercial sources and used without purification. Melting points (m.p.) were recorded using Electro thermal melting point apparatus (UK). Fouriertransform infrared spectra were recorded using Shimadzu FTIR-8400S infrared spectrophotometer by KBr disc (Kufa University). Proton nuclear magnetic resonance ( 1 H-NMR) and nuclear magnetic resonance ( 13 C-NMR) were recorded by Bruker spectrometer, operating at (400MHZ for 1 HNMR and 75 MHZ for 13 C NMR ) with DMSO-d 6 as a solvent (Abu Ali Center Lab, Mashhad, Iran). Thin layer chromatography (TLC) was performed on aluminum plates and coated with a layer of (0.25 mm) silica gel; compounds were detected by iodine vapor. Autoclave was used to sterilize agar media, supplied by Prestige MedicalEngland. Incubator was used to maintain different temperatures required for the growth of organism, supplied by Memert-Germany.
Synthesis of 2-chloro-N-(4-(N-pyrimidin-2-ylsulfamoyl)phenyl) acetamide[A] [10]
To a stirred mixture of sulfadiazine (0.01 mol) and triethylamine (1.67 mL) in dimethylformamide (DMF) as solvent, chloroacetyl chloride (0.01 mol) was added drop-wise by micropipette. After the addition was completed, the mixture was stirred for 3 h without heating. Finally, the solvent was evaporated, and the precipitate was filtered, dried and washed with distilled water-ether to give compound [A] . The crystalline precipitates were re-crystallized with ethanol. Yield: Pale yellow, 87 %; m.p. = 220 -222 °C; retardation factor (R f ) = 0.75; the TLC for the reaction was completed by using benzene : methanol = 4 : 1.
Synthesis of 4-(2-aminothiazol-4-ylamino)-N-(pyrimidin-2-yl)benzene sulfonamide [B] [11]
A mixture of [A] (0.01 mol), thiourea (0.01 mol) and anhydrous potassium carbonate (0.01 mol) in absolute ethanol (25 mL) was heated under reflux on water bath for 12 h. The excess of ethanol was removed by distillation and the residue was treated with 5% sodium carbonate solution to remove acid impurities. The yellow precipitate was filtered, washed with water several times and dried at 50 °C. Finally, the product was crystallized from ethanol. Yield: 78%; m.p.=178 -180 °C; R f = 0.58; benzene : methanol = 4 : 1 (Scheme 1).
2-chloro-N-(4-(4-(N-pyrimidin-2-ylsulfamoyl) phenylamino)thiazol-2-yl)acetamide[R] [12]
Preparation method of compound [R] was the same as preparation method of compound [A] in step 1: 0.01 mol of compound [B] and 0.01 mol of triethylamine in DMF; 0.01mol of chloroacetyl chloride was added drop-wise to the mixture. The reaction mixture was stirred for 4 h without heating. The product obtained after the evaporation of the solvent was filtered, washed with ether and re-crystallized with ethanol. Yield: Dark brown, 65%; m.p. = 211-213 °C; R f = 0.7; TLC for the reaction was completed by using benzene : methanol = 4 : 1. barbituric acid (0.01 mol) was dissolved in ethanol (20 mL) and distilled water (10 mL 
S y n t h e s i s
, D r y b e n z e n e was added. The mixture was refluxed for 4-5 h with stirring. The residue obtained was treated with ice-cold water (5 mL), filtered, dried in oven and recrystallized (Table 1 , Scheme 2).
Test of biological activity
Bacterial suspension was prepared from used bacteria and compared with McFarland tube 1.5 × 10 8 cell/mL which refers to the sensitivity prepared and the number of bacteria cultivated. Bacterial suspension was spread on Muller Hinton Agar homogeneously (0.1 mL) to cover the whole medium. Afterwards, three holes were made in the paten dish by the cork piercing to diameter of 6 mm at the concentration used. Diluted solutions of 0,03 and 0.06 mg/mL were prepared for each compound at pH 7. Then, the concentrated solutions prepared from chemical compounds were put in holes to reveal their effectiveness of biological activity. The paten dish was incubated at temperature 37 °C for 24 h. Finally, the diameter of inhibition zone for each disc was measured by the ruler to determine the effectiveness of each compound and compare it with the standard limits of sensitivity of the same species of bacteria against antibiotics [16] .
To examine the antifungal activity, 0,03 and 0.06 mg/mL of synthesized compounds were dissolved in 5 mL dimethyl sulfoxide as solvent, and evaluated in vitro employing the filter paper disc method against Candida albicans and Aspergillus flavus by measuring inhibition zone in millimetre [17] .
Results and Discussion
In this research, a series of new barbituric acid derivatives [RB 1 ]-[RB 4 ] containing thiazole moiety were synthesized from sulfa drug. Sulfadiazine is the starting material for this research, it was converted to 2-chloro-N-(4-(N-pyrimidin-2-ylsulfamoyl)phenyl) acetamide [A] by the reaction with chloroacetyl chloride and triethylamine in DMF as solvent. The synthesized compound [A] was characterized by sodium fusion test and the result was positive. The chlorine element was identified using saturated solution of AgNO 3 reagent; white precipitate was observed, which was due to the presence of chlorine in compound [A] . FTIR spectrum showed the disappearance of one absorption band at 3425 cm -1 which was due to the stretching vibrations of -NH 2 group of sulfadiazine, the remaining of the band at 3381 cm -1 which was due to the N-H group of amide, the absorption band at Control : DMSO 0 0 0 Fig. 1 Antibacterial activity of some synthesized compounds at (a) 0.03 mg/mL and (b) 0.06 mg/mL. Antifungal activity of the synthesized compounds was tested against two types of fungi, Candida albicans and Aspergillus flavus by using potato dextrose agar (PDA) medium. The test results are presented in Table 3 and Fig. 2. Compounds [B 4 ] was highly active at 0.03 mg/mL whereas inactive at 0.06 mg/mL. FTIR spectra for some compounds are presented in Fig. 3-6; 1 H-NMR and 13 C-NMR spectra for some compounds are presented in Fig. 7-12 ; and antimicrobial activities for some compounds are shown in Fig. 13 and 14 . 
υ(C-H) aromatic and (CH 2 -O)), 3170 (υ(C-H) and (HC=N) pyrimidine), 2862 (υ(C-H) aliphatic), 1375 and 1153 (υ(SO 2 )), 1240 (υ(C-O) and (C-O-C)), and 1091 (υ(C-O) and (C-O-H)

Antimicrobial activity
A n t i b a c t e r i a l a c t i v i t y o f t h e s y n t h e s i z e d compounds was tested against three types of bacteria,
